key: cord-0052080-q48e64af authors: Zughaier, Susu M.; Lubberts, Erik; Bener, Abdulbari title: Editorial: Immune-Modulatory Effects of Vitamin D date: 2020-09-29 journal: Front Immunol DOI: 10.3389/fimmu.2020.596611 sha: 2759e64afea69faf93bae3a04693566b3297d105 doc_id: 52080 cord_uid: q48e64af nan Vitamin D plays an essential role in bone development. However, recent studies are beginning to uncover its role as a modulator of the immune system (1) . Several reports have shown associations between vitamin D deficiency (2) and the incidence as well as the severity of chronic inflammatory diseases such as cardiovascular disease (3, 4) , inflammatory bowel disease (5) , asthma (6) , and chronic obstructive pulmonary disease (COPD) (7) . Consistent with this, vitamin D supplementations have been shown to reduce the severity of and inflammation markers in chronic inflammatory diseases (8) . At the molecular level, the hormonally active form of vitamin D (α1,25 dihydroxyvitamin D 3 ) regulates the expression of vitamin D responsive genes that can lead to differential regulation of signaling pathways in immune cells. For example, vitamin D positively regulates iron homeostasis and erythropoiesis via the iron-hepcidin-ferroportin axis (9) . Vitamin D deficiency is highly prevalent world-wide including countries with abundance of sunshine (10). Singh et al. reviewed the causes of vitamin D deficiency where they dissected the complex impact of genetic predisposition, gut microbiota, and immune system. In this review, authors examined GWAS database (11) and listed genes variants with SNPs that associate with risk of vitamin D deficiency. These alleles are common in vitamin D receptor (VDR) and vitamin D binding protein (VDPB). Since gut microbiota plays a crucial role in nutrients and vitamins production, absorption and degradation, authors also highlighted the role of vitamin D metabolism and VDR is regulating host-gut microbiota interactions. At the cellular level, vitamin D exerts anti-inflammatory effects on immune cells that express the vitamin D receptor (VDR) such as monocytes, macrophages, and T lymphocytes, which in turn shapes the immune response during the onset of inflammation and infection and following vaccination. Vitamin D exerts anti-inflammatory effects by reducing pro-inflammatory cytokines production from macrophages and T cells (12, 13) . Carlberg eloquently demonstrated that vitamin D/VDR signaling impacts chromatin modeling leading to significant modification of human monocytes epigenome during perturbation, consequently reducing cytokine release and modulating trained innate immunity. The immune modulatory effects of vitamin D include reduction in inflammatory cytokines release such as IL-1β, which is induced via inflammasome activation. Rao et al. showed that VDR inhibited NALP3-inflammasome activation leading to reduction in IL-1β release. To confirm the inhibitory effect of VDR on NLP3 inflammasome activation, authors used VDR-deficient mice and showed that IL-1β release was significantly reduced in vivo confirming that VDR inhibited NALP3 inflammasome activation. Vitamin D deficiency is associated with bone pain in particular and chronic disease pain in general (12, 14) . The proposed mechanisms by which Vitamin D/VDR signaling modulate pain sensation is reviewed by Habib et al.. Authors delineate vitamin D/VDR interactions with pain sensing pathways including dorsal root ganglion (DRG) neurons, nerve growth factor (NGF), epidermal growth factor receptor (EGFR), glial-derived neurotrophic factor (GDNF), and opioid receptors. Sufficient levels of vitamin D have been shown to regulate T cell proliferation by controlling T cell antigen receptor and T cell activation as well as enhancing the phagocytic activity of macrophages (12, 14) . The immune suppressive effects of regulatory T cells (T-reg) in controlling inflammation and preventing autoimmunity is well-established. Maternal immune tolerance to fetus is also integral to successful pregnancy. Vitamin D deficiency is quite common in pregnancy which has been associated with adverse outcomes. Cyprian et al. In cases of autoimmune diseases, low vitamin D levels are associated with increased B cell proliferation and autoantibody production. Low vitamin D levels have also been associated with the incidence of autoimmune diseases such as Rheumatoid Arthritis (RA), Multiple Sclerosis (MS), and Systemic Lupus Erythematosus (SLE) (15) . A systematic review by Islam et al. on the immunomodulatory effects of diet and nutrients in Systemic Lupus Erythematosus (SLE) presented the beneficial effect of vitamin D supplementation such as alleviating fatigue. Metaanalysis studies showed that SLE patients have significantly lower vitamin D levels compared to healthy participants. In human and animal studies of SLE, vitamin D is shown to inhibit cytokines such as IL-10, IL-17, IFN-γ, and modulate cellular proliferation of B-cells, Th1, Th17, CD4+ T cells. Therefore, vitamin D exerts various immune modulatory effects during autoimmune diseases. Another example of autoimmune diseases is Type 1 diabetes mellitus (T1DM) where insulin producing pancreatic β-cells are attacked by T cell-mediated autoimmunity (12, 16) . Stem cell transplantation has emerged as regenerative treatment for T1DM as it possess immune suppressive potential. A clinical trial (NCT03920397) conducted by Araujo et al. on the effect of vitamin D treatment with allogenic adipose tissue-derived stromal/stem cells (ASCs) in 13 patients with recent onset of T1DM. One group received ASC and vitamin D (cholecalciferol 2,000 UI/day) for 3 months while the second group received standard insulin therapy. They observed that allogenic ASC and vitamin D therapy lead to reduced insulin requirement and more stable C peptide. Low vitamin D status has been shown to be a risk factor for infectious diseases (17, 18) . During infections such as Tuberculosis (TB), vitamin D induces the expression of cathelicidin (LL-37), a host defense peptide that enhances the bactericidal activity of immune cells like macrophages, thereby limiting the growth of mycobacteria that causes TB (18) . Furthermore, LL-37 exerts anti-inflammatory effects via its ability to neutralize bacterial molecules like endotoxins and capsular polysaccharides that activate TLR signaling pathways, consequently inhibiting the release of pro-inflammatory mediators from macrophages. In this special topic several research papers investigated the role of vitamin Vitamin D deficiency increases the risk of bacterial and viral infections (17) . The immune modulatory effects of vitamin D during bacterial infections seem to vary from those effects during viral infections. In this regards, Anderson et al. observed the differential effects of vitamin D on induced inflammatory responses in primary human peripheral mononuclear cells (PBMC) during bacterial pneumococcal infection alone, respiratory syncytial viral (RSV) infection or coinfection. They showed that vitamin D exerted anti-inflammatory effects by reducing Th17 inflammatory cell expression and cytokines during pneumococcal infection alone and RSV alone but not during co-infection with RSV. Genetic predisposition plays a role in host susceptibility to infections (19) . Similarly, polymorphism in genes involved in vitamin D metabolism and function such as VDR impacts host susceptibility to infections. Pepineli et al. evaluated four genetic variants of VDR in the Leprosy immune pathogenesis in Brazil. They investigated a cohort of 404 leprosy patients in comparison to 432 control individuals without disease. Although no association is identified in VDR polymorphism genetic frequency between patients with active clinical leprosy and controls, they observed bAt haplotype to confer protection from leprosy. Taken together, data from original research paper, clinical trial, systematic analysis, and reviews included herein provide compelling evidence to the immune modulatory effects of vitamin D. Therefore, vitamin D deficiency should be treated to gain the extra skeletal beneficial effects on the immune system in health and disease. Immunologic effects of vitamin D on human health and disease Vitamin D deficiency 2.0: an update on the current status worldwide The role of vitamin D in obstructive sleep apnoea syndrome Micro-environment and intracellular metabolism modulation of adipose tissue macrophage polarization in relation to chronic inflammatory diseases Vitamin D and intestinal homeostasis: barrier, microbiota, immune modulation Vitamin D deficiency as a strong predictor of asthma in children The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis Vitamin D supplementation in the treatment of chronic heart failure: a metaanalysis of randomized controlled trials The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes Effect of vitamin D deficiency in developed countries Genome-wide association study of circulating vitamin D levels Vitamin D, autoimmune disease and rheumatoid arthritis 1,25(OH)2D3 and dexamethasone additively suppress synovial fibroblast activation by CCR6(+) T helper memory cells and enhance the effect of tumor necrosis factor alpha blockade Vitamin D as a potential therapy for multiple sclerosis: where are we? Vitamin D and systemic lupus erythematous: a review of immunological and clinical aspects Follicular helper T cells in type 1 diabetes The role of vitamin D deficiency in children with recurrent wheezing-clinical significance Role of vitamin-D supplementation in TB/HIV co-infected patients Sex-specific SARS-CoV-2 mortality: among hormone-modulated ACE2 expression, risk of venous thromboembolism and hypovitaminosis D SZ wrote the editorial. EL and AB reveiwed the editorial. All authors contributed to the article and approved the submitted version. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Copyright © 2020 Zughaier, Lubberts and Bener. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.